Salarius Pharmaceuticals, Inc. (SLRX)


Stock Price Forecast

April 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Salarius Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for Salarius Pharmaceuticals, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

14

Exchange

Nasdaq

$8M

Total Revenue

14

Employees

$2M

Market Capitalization

-0.09

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SLRX News

Salarius Pharmaceuticals Inc SLRX

17d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday

on MSN ago, source:

Dada Nexus shares gained 0.9% to $2.33 in after-hours trading. Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) posted a net ...

Salarius: Q4 Earnings Snapshot

1mon ago, source: Times Union

HOUSTON (AP) — HOUSTON (AP) — Salarius Pharmaceuticals, Inc. (SLRX) on Friday reported a loss of $882,000 in its fourth quarter. The Houston-based company said it had a loss of 22 cents per share.

Salarius Pharmaceuticals Inc (FP1.MU)

23d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Salarius Pharmaceuticals, Inc. (SLRX)

6d ago, source: Yahoo Finance

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Salarius Pharmaceuticals Inc SLRX

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Salarius Pharmaceuticals Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...